The patients examined in this study were the same cohort as in an earlier study of morphologic features2' but with additional follow-up. Between March 1978 and February 1982 , 100 patients were studied just prior to initial chemotherapy for MM; all were followed for at beast 3.5 years. than those with creatinine <2 mg/dL (Table  2) . Finally, patients with plasmablastic myeloma had a poorer survival than those who had nonplasmablastic myeboma (Table  2) .
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